Splenic marginal zone lymphoma: a review of the clinical presentation, pathology, molecular biology, and management
Splenic marginal zone lymphoma is a distinct low grade B-cell lymphoma primarily occurring in the spleen and separate from nodal marginal zone lymphoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. It is characterized by a relative indolent course, splenomegaly, moderat...
Saved in:
Published in | Blood and lymphatic cancer Vol. 4; no. default; pp. 29 - 38 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Macclesfield
Dove Medical Press Limited
01.01.2014
Taylor & Francis Ltd Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Splenic marginal zone lymphoma is a distinct low grade B-cell lymphoma primarily occurring in the spleen and separate from nodal marginal zone lymphoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. It is characterized by a relative indolent course, splenomegaly, moderate lymphocytosis, and an intrasinusoidal pattern of involvement, especially in the bone marrow. It is postulated that the neoplastic clone originates from persistent antigenic stimulation of marginal zone B-cells. Molecular and cytogenetic studies have failed to show specific alterations. There is no standard criterion to initiate treatment, which may include a watch and wait policy, splenectomy, or chemo/immunotherapy. This review highlights the main features of this entity, reassessing the guidelines for diagnosis, prognostic factors, staging, and management published by the SMZL Working Group (2008). Keywords: splenectomy, villous lymphocytes, guidelines |
---|---|
ISSN: | 1179-9889 1179-9889 |
DOI: | 10.2147/BLCTT.S49373 |